|
Journal of Lipid Research, Vol. 41, 613-620, April 2000
Copyright © 2000 by Lipid Research, Inc.
Altered immune responses in apolipoprotein E-deficient mice
D. T. Laskowitza,
D. M. Leea,
D. Schmechela, and
H. F. Staatsa,b
a Department of Medicine (Neurology), Duke University Medical Center, Durham, NC 27710
b Department of Immunology, Duke University Medical Center, Durham, NC 27710
Correspondence to:
D. T. Laskowitz
Apolipoprotein E (apoE) is a 34 kDa glycosylated protein with multiple biological properties. In addition to its role in cholesterol transport, apoE has in vitro immunomodulatory properties. Recent data suggest that these immunomodulatory effects of apoE may be biologically relevant, and apoE-deficient mice have altered immune responses after bacterial inoculation and increased susceptibility to endotoxemia induced by lipopolysaccharide (LPS). To better understand the mechanism by which apoE-modulates immune responses, we tested the role of human apoE isoforms in assays of human T cell proliferation, and analyzed the immune responses of apoE-deficient mice. Both the E3 and E4 isoforms of apoE induced similar suppression of human lymphocyte function in assays of T cell proliferation, including mitogenic responses to phytohaemagglutin (PHA), stimulation of the T cell receptor with CD3, and antigen-specific response to tetanus toxoid. ApoE-deficient mice showed no quantitative differences in thymic, splenic, or bone marrow lymphocyte populations, nor were there in vitro abnormalities in splenocyte proliferation after stimulation with CD3 to suggest an inherent T cell defect in apoE-deficient mice. ApoE deficient animals, however, had significantly higher levels of antigen-specific IgM after immunization with tetanus toxoid, and impaired delayed type hypersensitivity responses as compared to control C57-BL/6 mice.
These results support a growing body of evidence demonstrating an interplay between lipid metabolism and immune responses, and suggest that apoE plays a biologically relevant role in regulating humoral and cell-mediated immunity.Laskowitz, D. T., D. M. Lee, D. Schmechel, and H. F. Staats. Altered immune responses in apolipoprotein E-deficient mice. J. Lipid Res. 2000. 41: 613;620.
Supplementary key words:
apolipoprotein E, transgenic mice, immunity

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Li, P. A. Thompson, and R. L. Kitchens
Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors
J. Lipid Res.,
August 1, 2008;
49(8):
1782 - 1793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Grunfeld and K. R. Feingold
HDL and innate immunity: a tale of two apolipoproteins
J. Lipid Res.,
August 1, 2008;
49(8):
1605 - 1606.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Singh, R. Chaturvedi, M. Asim, D. P. Barry, N. D. Lewis, M. P. Vitek, and K. T. Wilson
The Apolipoprotein E-mimetic Peptide COG112 Inhibits the Inflammatory Response to Citrobacter rodentium in Colonic Epithelial Cells by Preventing NF-{kappa}B Activation
J. Biol. Chem.,
June 13, 2008;
283(24):
16752 - 16761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Hofmann, D. Perez-Tilve, T. M. Greer, B. A. Coburn, E. Grant, J. E. Basford, M. H. Tschop, and D. Y. Hui
Defective Lipid Delivery Modulates Glucose Tolerance and Metabolic Response to Diet in Apolipoprotein E Deficient Mice
Diabetes,
January 1, 2008;
57(1):
5 - 12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gourdy, A. Schambourg, C. Filipe, V. Douin-Echinard, B. Garmy-Susini, B. Calippe, F. Terce, F. Bayard, and J.-F. Arnal
Transforming Growth Factor Activity Is a Key Determinant for the Effect of Estradiol on Fatty Streak Deposit in Hypercholesterolemic Mice
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2007;
27(10):
2214 - 2221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kovacs, P. Tornvall, R. Nilsson, J. Tegner, A. Hamsten, and J. Bjorkegren
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia
PNAS,
August 21, 2007;
104(34):
13768 - 13773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Mullick, A. F. Powers, R. S. Kota, S. D. Tetali, J. P. Eiserich, and J. C. Rutledge
Apolipoprotein E3- and Nitric Oxide-Dependent Modulation of Endothelial Cell Inflammatory Responses
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2007;
27(2):
339 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Yates and M. Stafford-Smith
The genetic determinants of renal impairment following cardiac surgery.
Seminars in Cardiothoracic and Vascular Anesthesia,
December 1, 2006;
10(4):
314 - 326.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tormakangas, J. Ketonen, M. Leinonen, P. Saikku, and I. Paakkari
Increased prostanoid dependency of arterial relaxation in Chlamydia pneumoniae-infected mice.
J. Med. Microbiol.,
August 1, 2006;
55(Pt 8):
1017 - 1021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-M. Cheon, S. W. Shin, G. Bian, J.-H. Park, and A. S. Raikhel
Regulation of Lipid Metabolism Genes, Lipid Carrier Protein Lipophorin, and Its Receptor during Immune Challenge in the Mosquito Aedes aegypti
J. Biol. Chem.,
March 31, 2006;
281(13):
8426 - 8435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Grainger, J. Reckless, and E. McKilligin
Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice
J. Immunol.,
November 15, 2004;
173(10):
6366 - 6375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. A. Whitten, I. F. Tew, B. L. Lee, and N. A. Ratcliffe
A Novel Role for an Insect Apolipoprotein (Apolipophorin III) in {beta}-1,3-Glucan Pattern Recognition and Cellular Encapsulation Reactions
J. Immunol.,
February 15, 2004;
172(4):
2177 - 2185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Lynch, W. Tang, H. Wang, M. P. Vitek, E. R. Bennett, P. M. Sullivan, D. S. Warner, and D. T. Laskowitz
APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response
J. Biol. Chem.,
December 5, 2003;
278(49):
48529 - 48533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Naghavi, P. Wyde, S. Litovsky, M. Madjid, A. Akhtar, S. Naguib, M. S. Siadaty, S. Sanati, and W. Casscells
Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E-Deficient Mice
Circulation,
February 11, 2003;
107(5):
762 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. Kunjathoor, D. S. Chiu, K. D. O'Brien, and R. C. LeBoeuf
Accumulation of Biglycan and Perlecan, but Not Versican, in Lesions of Murine Models of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2002;
22(3):
462 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. K. Misra, C. L. Adlakha, G. Gawdi, M. K. McMillian, S. V. Pizzo, and D. T. Laskowitz
Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages
J. Leukoc. Biol.,
October 1, 2001;
70(4):
677 - 683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Drabe, G. Zund, J. Grunenfelder, M. Sprenger, S. P. Hoerstrup, L. Bestmann, F. E. Maly, and M. Turina
Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines
Eur. J. Cardiothorac. Surg.,
September 1, 2001;
20(3):
609 - 613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. P. Grocott, M. F. Newman, H. El-Moalem, D. Bainbridge, A. Butler, and D. T. Laskowitz
Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg.,
September 1, 2001;
122(3):
622 - 623.
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|